<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets	</title>
	<atom:link href="https://9krapalm.com/biosion-announces-exclusive-global-license-agreement-with-aclaris-therapeutics-on-two-potential-first-in-class-and-best-in-class-immunology-assets/feed/" rel="self" type="application/rss+xml" />
	<link>https://9krapalm.com/biosion-announces-exclusive-global-license-agreement-with-aclaris-therapeutics-on-two-potential-first-in-class-and-best-in-class-immunology-assets/</link>
	<description>เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm</description>
	<lastBuildDate>Mon, 18 Nov 2024 14:54:14 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>
</channel>
</rss>
